Showing results (621-630 of 638) with videos related to
Sort By:
Pageof 64
Plos One|December 15, 2010
A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosisCarlos Riveros, Drew Mellor, Kaushal S Gandhi, et al.Data in Brief|March 10, 2017
Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosisN Fewings, P N Gatt, F C McKay, et al.Biochemistry|June 29, 2017
Adenosine Monophosphate Binding Stabilizes the KTN Domain of the Shewanella denitrificans Kef Potassium Efflux SystemChristos Pliotas, Samuel C Grayer, Silvia Ekkerman, et al.Journal of Autoimmunity|January 9, 2017
The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosisN L Fewings, P N Gatt, F C McKay, et al.JAMA Neurology|March 7, 2018
Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse ModelRebecca K Sheean, Fiona C McKay, Erika Cretney, et al.Plos One|November 5, 2010
A polymorphism in the HLA-DPB1 gene is associated with susceptibility to multiple sclerosisJudith Field, Sharon R Browning, Laura J Johnson, et al.Gut|September 13, 2014
Impact of common risk factors of fibrosis progression in chronic hepatitis CS Rüeger, P-Y Bochud, J-F Dufour, et al.Ciba Foundation Symposium|January 1, 1996
Molecular mechanisms of fibrillogenesis and the protective role of amyloid P component: two possible avenues for therapyM B Pepys, G A Tennent, D R Booth, et al.Nature Genetics|April 11, 2017
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosisMohammed Eslam, Duncan McLeod, Kebitsaone Simon Kelaeng, et al.Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.Pageof 64